The Medical Applications of Novel PET Radiopharmaceuticals. [PDF]
Vigne J, Besson FL.
europepmc +1 more source
Comparative Evaluation of Release Profiles from Hydrogel, Oleogel, and Bigel Systems Containing Model Radiopharmaceuticals for Buccal Delivery. [PDF]
Güneş M +3 more
europepmc +1 more source
Stability assessment of PET radiopharmaceuticals under extreme conditions: an ICH-compliant study on radiochemical and enantiomeric purity. [PDF]
Forgács V +4 more
europepmc +1 more source
Radiopharmaceuticals in Renal Imaging: A Comprehensive Review of Current Applications and Future Prospects. [PDF]
Battal-Kaplan H +2 more
europepmc +1 more source
Comparative study of <sup>18</sup>F-labeled PET radiopharmaceuticals in an Alzheimer's disease mouse model. [PDF]
Park BN, Kim SM, An YS.
europepmc +1 more source
Liquid chromatographic determination of enantiomeric purity of [<sup>11</sup>C]methyl-L-methionine and O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine by pre-column derivatization with o-phthaldialdehyde and N-isobutyryl-L-cysteine. [PDF]
Forgács V +8 more
europepmc +1 more source
Drug interactions involving therapeutic radiopharmaceuticals: a systematic review. [PDF]
Gacon R +10 more
europepmc +1 more source
Quality control of actinium-225 and <sup>225</sup>Ac-radiopharmaceuticals: Francium-221 to be or not to be? [PDF]
Toro-Gonzalez M +10 more
europepmc +1 more source
<sup>225</sup>Ac-NOTA-trastuzumab human dosimetry using inter-radionuclide and biological half-life based allometric extrapolation method. [PDF]
Almaslamani M +5 more
europepmc +1 more source
Macrocyclic and Hydroxamate Ligands for <sup>225</sup>Ac Radiopharmaceuticals: Evaluating SSTR2-Targeting Potential. [PDF]
Tsushima S +4 more
europepmc +1 more source

